北京市丰台区老年人免费流感疫苗接种效果评价

doi:10.3969/j.issn.1006-3110.2022.09.011

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (703 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的评价北京市丰台区老年人接种免费流感疫苗的效果。方法随机抽取丰台区2019年10—11月434名接种免费流感疫苗的60周岁以上的老年人作为接种组,选取2019年未接种流感疫苗的60周岁以上的434名老年人作为对照组。采用统一设计的调查问卷,收集调查对象的基本情况、接种疫苗后一年内流感样病例、呼吸系统疾病和心脑血管疾病的发生及就诊情况。结果接种免费流感疫苗3个月内,接种组流感样病例的发病率(1.61%)低于对照组的发病率(5.07%),差异有统计学意义(χ²=8.027,P=0.005)。接种免费流感疫苗3个月内、4~6个月、7~12个月流感样病例的保护率分别为68.24%、16.67%、25.00%,流感样病例就医行为的保护率分别为40.00%、25.00%、50.00%;呼吸系统疾病的保护率分别为25.45%、-29.93%、-67.03%,呼吸系统疾病就医行为的保护率分别为19.97%、-8.70%、-57.14%;心脑血管系统疾病的保护率分别为40.00%、16.67%、-25.00%,心脑血管系统疾病就医行为的保护率分别为60.00%、75.00%、-25.00%。结论老年人接种流感疫苗可明显减少流感样病例的发生。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	姜晓飞
	唐田
	毛雯雯

关键词 ：老年人, 流感疫苗, 保护效果

Abstract：Objective To estimate the effectiveness of free influenza vaccination in elderly population in Fengtai District, Beijing. Methods We randomly selected 434 senior citizens inoculated with free influenza vaccines and aged above 60 years in Fengtai District of Beijing from October to November 2019 to serve as the vaccinated group, and 434 elderly people over 60 years old who were not vaccinated against the flu in 2019 were selected as the control group. A uniformly designed questionnaire was used to collect the general information of the subjects, and the incidence andtreatment seekingof influenza-like cases, respiratory diseases and cardiovascular and cerebrovascular diseases within one year after vaccination. Results The incidence of influenza-like illness in the vaccinated group (1.61%) was significantly lower than that in the control group (5.07%) within 3 months after the free influenza vaccination, with a statistically significant difference (χ²=8.027, P=0.005). The rates of protectiveeffectagainst influenza-like illness within 3, 4-6 and 7-12 months after free influenza vaccination were 68.24%, 16.67% and 25.00%, respectively, and the protective rates of seeking medical treatment due to influenza-like illness were 40.00%, 25.00% and 50.00%, respectively. The protective rates of respiratory system diseases were 25.45%, -29.93% and -67.03%, respectively, and the protective rates of seeking medical treatment due to respiratory system diseases were 19.97%, -8.70% and -57.14%, respectively. The protective rates of cardiovascular and cerebrovascular diseases were 40.00%, 16.67% and -25.00%, respectively, and the protective rate of seeking medical treatment for cardiovascular and cerebrovascular diseases were 60.00%, 75.00% and -25.00%, respectively. Conclusion Influenza vaccination for the elderly can significantly reduce the incidence of influenza like illness.

Key words： the elderly influenza vaccine protective effectiveness

收稿日期: 2021-11-09

R186

基金资助:北京市丰台区卫生健康系统科研项目(2019-137)

作者简介: 姜晓飞(1987-),女,山东人,硕士,主管医师,研究方向:疫苗针对传染病监测与控制工作。

引用本文:

姜晓飞, 唐田, 毛雯雯. 北京市丰台区老年人免费流感疫苗接种效果评价[J]. 实用预防医学, 2022, 29(9): 1068-1071. JIANG Xiao-fei, TANG Tian, MAO Wen-wen. Evaluation on effectiveness of free influenza vaccination among the elderly in Fengtai District of Beijing. , 2022, 29(9): 1068-1071.

链接本文:

https://www.syyfyx.com/CN/10.3969/j.issn.1006-3110.2022.09.011 或 https://www.syyfyx.com/CN/Y2022/V29/I9/1068

[1] Michael M, Helm E, Van Graaeiland B, et al. Influenza vaccination with a live attenuated vaccine[J]. Am J Nurs, 2009, 109(10):44-48.
[2] Somes MP,Turner RM,Dwyer LJ,et al. Estimating the annual attackrate of seasonal influenza among unvaccinated individuals: a systematic review and meta-analysis[J]. Vaccine, 2018, 36(23):3199-3207.
[3] Iuliano AD,Roguski KM,Chang HH,et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study[J]. Lancet,2018,391(10127):1825-1300.
[4] Lee J,Lam G,Shin T, et al. Efficacy and effectiveness of high-dose influenza vaccine in older adults by circulating strain and antigenic match: an updated systematic review and meta-analysis[J]. Vaccine,2021,39(1):A24-A35.
[5] 杨孝坤,王蕾,赵宏婷,等.公众流感疫苗认知、接种现状及影响因素分析[J].实用预防医学,2021,28(6):653-657.
[6] 北京市丰台区统计局. 北京市丰台区第七次全国人口普查公报[EB/OL]. (2021-06-18)[2021-11-01]. http://www.bjft.gov.cn/ftq/pcgb/202106/8e6cc04bd7254e51bf44a86c59805444.shtml.
[7] 国家免疫规划技术工作组流感疫苗工作组.中国流感疫苗预防接种技术指南(2019—2020)[J]. 中华预防医学杂志,2020,54(1):21-36.
[8] 中华预防医学会流感预防控制工作委员会.促进老年人季节性流感疫苗接种专家共识[J].中华医学杂志,2021,101(8):530-538.
[9] 靳妍,符剑,何寒青,等.台州市 2018/2019年度社区老年人接种流感疫苗的保护效果[J].中国疫苗和免疫, 2021, 27(1):102-106.
[10] 星一,刘民. 流感灭活疫苗在中国应用效果的 Meta 分析[J]. 中华流行病学杂志, 2009, 30(4):368-370.
[11] 徐喜卿,李顺平.我国甲型 H1N1 流感疫苗免疫效果评估系统综述[J].实用预防医学,2016, 23(4):506-509.
[12] 马春娜,吴双胜,张莉,等.北京市2015—2020年流感流行季流感样病例和流感病原学分析[J]. 中华实验和临床病毒学杂志,2021,35(1):44-48.
[13] 崔丽萍,张杰,唐文睿,等.北京市某社区老年人群流感疫苗接种的效果观察[J].解放军护理杂志,2009,26(8A):11-13.
[14] 董振英,吴疆,褚天新,等.流行性感冒疫苗保护效果和成本效益分析[J].中华流行病学杂志,2003,24(1):80-82.
[15] 宋倩倩,张艳平.某市65岁以上参保人员流感疫苗接种的效果观察[J].中国医药指南,2014,12(34):84-85.
[16] 刘民, 刘改芬, 王岩,等. 北京市老年人群流行性感冒疫苗免疫效果及成本效益评价[J]. 中华流行病学杂志, 2005,26(6):412-416.
[17] 孙品晶,董莹,李清,等.海宁市老年人流感疫苗接种效果评价[J].预防医学,2020,32(9):929-932.
[18] 国务院应对新型冠状病毒肺炎疫情联防联控机制综合组.关于印发新型冠状病毒肺炎防控方案(第八版)的通知[EB/OL]. (2021-05-11)[2021-05-14]. http://www.gov.cn/xinwen/2021-05/14/content_5606469.htm.
[19] 王佩婷,董一颍,向国安,等.新型冠状病毒肺炎疫情对驻京非定点医院呼吸科门诊影响分析[J].中华灾害救援医学,2020,8(11):612-614.
[20] 段玮,杨鹏,石伟先,等.流感疫苗的安全性和效果效益研究[J].国际病毒学杂志,2014,21(6):241-244.
[21] 邓鹏,李琼,钱小爱,等.基于大样本流感病毒裂解疫苗上市后安全性监测分析[J]. 公共卫生与预防医学,2020,31(3):33-35.